Global Facial Injectable Market by Application (Aesthetic, Therapeutic), by Product (Calcium Hydroxylapatite, Polymer Fillers, Hyaluronic Acid, Collagen, Botulinum Toxin Type A) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global facial injectables market was valued at USD 13.4 Billion in 2020. It is expected to grow at an 8.8% compound annual growth rate (CAGR), between 2021 and 2028. In recent years, consumers have been more concerned about their physical appearance and facial injectables are in high demand. Video calls have been increasing due to the ongoing COVID-19 epidemic. The 'Zoom Boom' is a term that describes an increase in awareness about one's appearance. Botox is one of the most sought-after cosmetic procedures. Cosmetic surgery is becoming more popular due to the ease of recovery at home. The market saw a surge during the pandemic.
Invasive surgeries are being replaced by minimally invasive procedures. According to the American Society of Plastic Surgeons, almost 17.7 million minimally-invasive and surgical cosmetic procedures were performed in the U.S. in 2018. Nearly 15.9 million of these products were minimally invasive. The market for facial injectables is being driven by the growing acceptance of minimally invasive procedures and the wide availability of treatment options.
The International Society of Aesthetic Plastic Surgery, (ISAPS) ranked the United States 1 and 1 for non-surgical products at a global level. Injectables like botulinum toxins and hyaluronic acids were the most commonly used. With over 7,000 surgeons, the country has access to advanced treatments and is home to some of the most skilled surgeons in the world. These factors are important for market growth.
Impact of COVID19: A 51% rise in demand is anticipated in the next few years
|
Pandemic Impact |
Outlook after COVID |
|
Aesthetic practices have been negatively affected by the imposition of national lockdowns, and subsequent closing of clinics. Hamilton Fraser conducted a survey and found that nearly 99.78% reported that their practice was affected in 2020 by the COVID-19 pandemic. Around 80.51% of practitioners reported the closing of clinics, 67.28% reporting a reduction in revenue, and 63.31% reporting fewer inquiries. |
To ensure patient engagement, practitioners will be focusing more on digital consultations after the death of covid. |
|
AbbVie reported a decline in Botox sales during Q2 2020 because of the COVID-19 pandemic. AbbVie Inc purchased Allergan May 2020. |
Cynosure conducted a survey and found that 62% of practitioners felt confident in their ability to restore business revenue to pre-Covid levels within twelve months of lifting impositions |
|
Patients have expressed fear after experiencing adverse reactions to Moderna COVID-19 vaccination in patients who use dermal fillers. |
Allergan Aesthetics (a subsidiary of AbbVie Inc. in the U.S.) received FDA approval for JUVEDERM VOLUMA XC to augment the chin region in adults aged 21 and older. Jeuveau was approved by FDA in 2019. It is similar to Botox but costs less than Botox. It is effective in reducing wrinkles.
Product Insights
Botulinum Toxin Type A dominated the facial injectable market, accounting for 55.2% of the total revenue in 2020. Women in their middle years are choosing fillers and injectables, including Botox to reverse signs of aging. At a CAGR 9.4%, the Hyaluronic Acid segment (HA) will be the fastest-growing. It is well-known for its ability to retain moisture in the skin. This makes the skin appear healthier. HA is known for its moisture-binding property, which helps to increase and maintain the vital moisture that makes the skin plump.
Application Insights
Market leader, the aesthetics segment will account for 70% of the total revenue in 2020. This is due to an increase in facial injectables used for aesthetic procedures like facial lines, wrinkles on face and lips lines.
In the next few years, facial injectables for aesthetic purposes will be in high demand due to the growing interest in personal appearance and the increase in disposable income in middle-class countries like India. Over the forecast period, the therapeutic segment will see a double-digit increase in CAGR. This can be attributed to the increasing use of facial injectables for treatment of blepharospasm and strabismus, Meige's Syndrome, Oromandibular Dystonia, Hemifacial Spasms, (HFS), and focal hyperhidrosis.
Regional Insights
North America was the dominant market, accounting for more than 41.0% of the total revenue in 2020. This is due to the large geriatric population of the U.S.A and Canada, which is expected to drive the demand for facial injections over the forecast period.
The American Society of Plastic Surgeons (ASPS) compared the rate of growth in cosmetic surgery products between 2000 and 2018. The use of Botox injections grew by 845%, according to the ASPS. In the future, North America will be a major revenue source for facial injectables.
The market in Asia Pacific is expected to see the highest CAGR at 10.0% over the forecast period. Countries such as South Korea, Australia, and India are supporting the region. The demand for facial injections will rise due to the growing attention being paid to the appearance of these developing countries. India is expected to grow at the fastest rate during the forecast period.
Market Share Insights & Key Companies
The major players are focusing their growth strategies on product launches and approvals, enhancements in existing technologies, geographic expansion, product launches, product launches, as well as product approvals. In 2019, Allergan launched a TV commercial for Botox Cosmetics, a brand that caters to millennials. According to the American Academy of Facial and Reconstructive surgery, Botox injections have grown by 22% in the last five years among those aged 22 to 37. The ad campaign focuses on the year that the product was launched by the company. The following are some of the most prominent players in facial injectables market:
-
Allergan
-
Hologic (cynosure).
-
Johnson & Johnson
-
Galderma
-
Lumenis
-
Solta Medical
-
Syneron Candela
-
Alma Laser
Up Market Research published a new report titled “Facial Injectable Market research report which is segmented by Application (Aesthetic, Therapeutic), by Product (Calcium Hydroxylapatite, Polymer Fillers, Hyaluronic Acid, Collagen, Botulinum Toxin Type A), By Players/Companies Allergan, Lumenis, Alma Laser, Galderma, Johnson & Johnson, Hologic (cynosure), Solta Medical, Syneron Candela”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Facial Injectable Market Research Report |
| By Application | Aesthetic, Therapeutic |
| By Product | Calcium Hydroxylapatite, Polymer Fillers, Hyaluronic Acid, Collagen, Botulinum Toxin Type A |
| By Companies | Allergan, Lumenis, Alma Laser, Galderma, Johnson & Johnson, Hologic (cynosure), Solta Medical, Syneron Candela |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 223 |
| Number of Tables & Figures | 157 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Facial Injectable Market Report Segments:
The market is segmented by Application (Aesthetic, Therapeutic), by Product (Calcium Hydroxylapatite, Polymer Fillers, Hyaluronic Acid, Collagen, Botulinum Toxin Type A).
Facial Injectable Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Facial Injectable Market
Overview of the regional outlook of the Facial Injectable Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Facial Injectable Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Facial Injectable Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Aesthetic
2. Therapeutic
7. By Product:1. Calcium Hydroxylapatite
2. Polymer Fillers
3. Hyaluronic Acid
4. Collagen
5. Botulinum Toxin Type A
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Facial Injectable Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Facial Injectable Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Facial Injectable Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Facial Injectable Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Facial Injectable Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Facial Injectable Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Facial Injectable Market Size & Forecast, 2018-2028
4.5.1 Facial Injectable Market Size and Y-o-Y Growth
4.5.2 Facial Injectable Market Absolute $ Opportunity
Chapter 5 Global Facial Injectable Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Facial Injectable Market Size Forecast by Application
5.2.1 Aesthetic
5.2.2 Therapeutic
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Facial Injectable Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Facial Injectable Market Size Forecast by Product
6.2.1 Calcium Hydroxylapatite
6.2.2 Polymer Fillers
6.2.3 Hyaluronic Acid
6.2.4 Collagen
6.2.5 Botulinum Toxin Type A
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Facial Injectable Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Facial Injectable Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Facial Injectable Analysis and Forecast
9.1 Introduction
9.2 North America Facial Injectable Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Facial Injectable Market Size Forecast by Application
9.6.1 Aesthetic
9.6.2 Therapeutic
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
9.10 North America Facial Injectable Market Size Forecast by Product
9.10.1 Calcium Hydroxylapatite
9.10.2 Polymer Fillers
9.10.3 Hyaluronic Acid
9.10.4 Collagen
9.10.5 Botulinum Toxin Type A
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Facial Injectable Analysis and Forecast
10.1 Introduction
10.2 Europe Facial Injectable Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Facial Injectable Market Size Forecast by Application
10.6.1 Aesthetic
10.6.2 Therapeutic
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 Europe Facial Injectable Market Size Forecast by Product
10.10.1 Calcium Hydroxylapatite
10.10.2 Polymer Fillers
10.10.3 Hyaluronic Acid
10.10.4 Collagen
10.10.5 Botulinum Toxin Type A
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Facial Injectable Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Facial Injectable Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Facial Injectable Market Size Forecast by Application
11.6.1 Aesthetic
11.6.2 Therapeutic
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Asia Pacific Facial Injectable Market Size Forecast by Product
11.10.1 Calcium Hydroxylapatite
11.10.2 Polymer Fillers
11.10.3 Hyaluronic Acid
11.10.4 Collagen
11.10.5 Botulinum Toxin Type A
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Facial Injectable Analysis and Forecast
12.1 Introduction
12.2 Latin America Facial Injectable Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Facial Injectable Market Size Forecast by Application
12.6.1 Aesthetic
12.6.2 Therapeutic
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Latin America Facial Injectable Market Size Forecast by Product
12.10.1 Calcium Hydroxylapatite
12.10.2 Polymer Fillers
12.10.3 Hyaluronic Acid
12.10.4 Collagen
12.10.5 Botulinum Toxin Type A
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Facial Injectable Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Application
13.6.1 Aesthetic
13.6.2 Therapeutic
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Product
13.10.1 Calcium Hydroxylapatite
13.10.2 Polymer Fillers
13.10.3 Hyaluronic Acid
13.10.4 Collagen
13.10.5 Botulinum Toxin Type A
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Facial Injectable Market: Competitive Dashboard
14.2 Global Facial Injectable Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Lumenis
14.3.3 Alma Laser
14.3.4 Galderma
14.3.5 Johnson & Johnson
14.3.6 Hologic (cynosure)
14.3.7 Solta Medical
14.3.8 Syneron Candela
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Facial Injectable Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Facial Injectable Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Facial Injectable Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Facial Injectable Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Facial Injectable Market Size & Forecast, 2018-2028
4.5.1 Facial Injectable Market Size and Y-o-Y Growth
4.5.2 Facial Injectable Market Absolute $ Opportunity
Chapter 5 Global Facial Injectable Market Analysis and Forecast by Application
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Application
5.1.2 Basis Point Share (BPS) Analysis by Application
5.1.3 Absolute $ Opportunity Assessment by Application
5.2 Facial Injectable Market Size Forecast by Application
5.2.1 Aesthetic
5.2.2 Therapeutic
5.3 Market Attractiveness Analysis by Application
Chapter 6 Global Facial Injectable Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Facial Injectable Market Size Forecast by Product
6.2.1 Calcium Hydroxylapatite
6.2.2 Polymer Fillers
6.2.3 Hyaluronic Acid
6.2.4 Collagen
6.2.5 Botulinum Toxin Type A
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Facial Injectable Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Facial Injectable Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Facial Injectable Analysis and Forecast
9.1 Introduction
9.2 North America Facial Injectable Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Facial Injectable Market Size Forecast by Application
9.6.1 Aesthetic
9.6.2 Therapeutic
9.7 Basis Point Share (BPS) Analysis by Application
9.8 Absolute $ Opportunity Assessment by Application
9.9 Market Attractiveness Analysis by Application
9.10 North America Facial Injectable Market Size Forecast by Product
9.10.1 Calcium Hydroxylapatite
9.10.2 Polymer Fillers
9.10.3 Hyaluronic Acid
9.10.4 Collagen
9.10.5 Botulinum Toxin Type A
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Facial Injectable Analysis and Forecast
10.1 Introduction
10.2 Europe Facial Injectable Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Facial Injectable Market Size Forecast by Application
10.6.1 Aesthetic
10.6.2 Therapeutic
10.7 Basis Point Share (BPS) Analysis by Application
10.8 Absolute $ Opportunity Assessment by Application
10.9 Market Attractiveness Analysis by Application
10.10 Europe Facial Injectable Market Size Forecast by Product
10.10.1 Calcium Hydroxylapatite
10.10.2 Polymer Fillers
10.10.3 Hyaluronic Acid
10.10.4 Collagen
10.10.5 Botulinum Toxin Type A
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Facial Injectable Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Facial Injectable Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Facial Injectable Market Size Forecast by Application
11.6.1 Aesthetic
11.6.2 Therapeutic
11.7 Basis Point Share (BPS) Analysis by Application
11.8 Absolute $ Opportunity Assessment by Application
11.9 Market Attractiveness Analysis by Application
11.10 Asia Pacific Facial Injectable Market Size Forecast by Product
11.10.1 Calcium Hydroxylapatite
11.10.2 Polymer Fillers
11.10.3 Hyaluronic Acid
11.10.4 Collagen
11.10.5 Botulinum Toxin Type A
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Facial Injectable Analysis and Forecast
12.1 Introduction
12.2 Latin America Facial Injectable Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Facial Injectable Market Size Forecast by Application
12.6.1 Aesthetic
12.6.2 Therapeutic
12.7 Basis Point Share (BPS) Analysis by Application
12.8 Absolute $ Opportunity Assessment by Application
12.9 Market Attractiveness Analysis by Application
12.10 Latin America Facial Injectable Market Size Forecast by Product
12.10.1 Calcium Hydroxylapatite
12.10.2 Polymer Fillers
12.10.3 Hyaluronic Acid
12.10.4 Collagen
12.10.5 Botulinum Toxin Type A
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Facial Injectable Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Application
13.6.1 Aesthetic
13.6.2 Therapeutic
13.7 Basis Point Share (BPS) Analysis by Application
13.8 Absolute $ Opportunity Assessment by Application
13.9 Market Attractiveness Analysis by Application
13.10 Middle East & Africa (MEA) Facial Injectable Market Size Forecast by Product
13.10.1 Calcium Hydroxylapatite
13.10.2 Polymer Fillers
13.10.3 Hyaluronic Acid
13.10.4 Collagen
13.10.5 Botulinum Toxin Type A
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Facial Injectable Market: Competitive Dashboard
14.2 Global Facial Injectable Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Lumenis
14.3.3 Alma Laser
14.3.4 Galderma
14.3.5 Johnson & Johnson
14.3.6 Hologic (cynosure)
14.3.7 Solta Medical
14.3.8 Syneron Candela
Segments Covered in the Report
The global Facial Injectable market has been segmented based on
By Application
The global Facial Injectable market has been segmented based on
By Application
- Aesthetic
- Therapeutic
- Calcium Hydroxylapatite
- Polymer Fillers
- Hyaluronic Acid
- Collagen
- Botulinum Toxin Type A
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Allergan
- Lumenis
- Alma Laser
- Galderma
- Johnson & Johnson
- Hologic (cynosure)
- Solta Medical
- Syneron Candela
Our Clients
Related Reports
Some other reports from this category!
